Health Canada updates Canadians on its ongoing assessment of nitrosamine impurities in certain drugs
In plain language
This recall involves certain "sartan" angiotensin receptor blocker (ARB) blood pressure medications and ranitidine drugs sold in Canada. They are being recalled because they may contain nitrosamine impurities above acceptable levels. Health Canada advises patients to continue taking their medication until they have discussed alternative treatments with their healthcare provider.
What to do
- Do not stop taking your medication without consulting your doctor or pharmacist.
- Talk to your doctor or pharmacist about alternative treatment options.
- Report any health product adverse events or complaints to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Potential cancer risk from nitrosamine impurities
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Potential cancer risk from nitrosamine impurities
What should consumers do?
Do not stop taking your medication without consulting your doctor or pharmacist. Talk to your doctor or pharmacist about alternative treatment options. Report any health product adverse events or complaints to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Potential cancer risk from nitrosamine impurities
When was this product recalled?
This product was recalled on December 2, 2019.